Tickers
Ardent Health (ARDT) held its Q3 2026 earnings call on November 5, 2026, with CEO David Caspers and CFO Alfred Lumsdaine presenting. Analysts from KeyBanc, UBS, Mizuho, RBC, Morgan Stanley, BofA, Guggenheim, BMO, Goldman Sachs and JPMorgan participated in the call. The provided transcript excerpt contains only opening remarks and no financial results or guidance figures.
Ardent Health, Inc. (ARDT) held its third quarter 2026 earnings conference call on November 5, 2026, at 10:00 AM EST, according to the call transcript.
Call Participants
Company participants:
- David Styblo — Senior Vice President of Investor Relations
- David Caspers — President, CEO & Director
- Alfred Lumsdaine — Chief Financial Officer
Conference call participants:
- Matthew Gillmor — KeyBanc Capital Markets Inc., Research Division
- Albert Rice — UBS Investment Bank, Research Division
- Ann Hynes — Mizuho Securities USA LLC, Research Division
- Benjamin Hendrix — RBC Capital Markets, Research Division
- Craig Hettenbach — Morgan Stanley, Research Division
- Kevin Fischbeck — BofA Securities, Research Division
- Jason Cassorla — Guggenheim Securities, LLC, Research Division
- Sean Dodge — BMO Capital Markets Equity Research
- Sarah Conrad — Goldman Sachs Group, Inc., Research Division
- Benjamin Rossi — JPMorgan Chase & Co, Research Division
Opening Remarks
The operator opened the call by welcoming participants to the Ardent Health Third Quarter 2026 Earnings Conference Call and noting that the line was in a listen-only mode, with instructions for questions to follow. The operator then handed the conference over to Dave Styblo, Lead Investor Relations.
The available transcript excerpt covers only these opening remarks. It does not include financial results, guidance, or management commentary from the prepared remarks or question-and-answer session.